When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRNB - Principia Bio's lead candidate successful in mid-stage pemphigus study
Principia Biopharma Inc.
Thinly traded Principia Biopharma (PRNB+1.1%) is up, albeit on turnover of only 5K shares, following its announcement of positive results from an open-label Phase 2 clinical trial evaluating its lead candidate, Orphan Drug-tagged PRN1008, in pemphigus patients. The data were presented at the American Academy of Dermatology Annual Meeting in Washington, DC.
More news on: Principia Biopharma, Healthcare stocks news, Stocks on the move,